Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Design of clinical trials requires careful decision-making across several dimensions, including endpoints, eligibility criteria, and subgroup enrichment. Clinical trial simulation can be an informative tool in trial design, providing empirical evidence by which to evaluate and compare the results of...

Descripció completa

Dades bibliogràfiques
Autors principals:	Weinstein, SM, Coates, LC, Helliwell, PS, Ogdie, A, Stephens-Shields, AJ
Format:	Journal article
Idioma:	English
Publicat:	SAGE Publications 2021

Ítems similars

Psoriatic arthritis: prospects for the future
per: Hackett, S, et al.
Publicat: (2022)

Measuring outcomes in psoriatic arthritis
per: Ogdie, A, et al.
Publicat: (2020)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
per: P.S. Helliwell
Publicat: (2011-09-01)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
per: Helliwell, PS, et al.
Publicat: (2022)

What should be the primary target of "treat to target" in psoriatic arthritis?
per: Coates, LC, et al.
Publicat: (2018)

Psoriatic arthritis: prospects for the future
per: Simon Hackett, et al.
Publicat: (2022-03-01)

Psoriatic arthritis
per: FitzGerald, O, et al.
Publicat: (2021)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
per: Ye, W, et al.
Publicat: (2021)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
per: Ogdie, A, et al.
Publicat: (2023)

The role of ultrasound in psoriatic arthritis — do we need a score?
per: D'Agostino, MA, et al.
Publicat: (2019)

Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
per: Coates, LC, et al.
Publicat: (2022)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
per: Ye, W, et al.
Publicat: (2021)

Current concepts and unmet needs in psoriatic arthritis
per: Mahmood, F, et al.
Publicat: (2017)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
per: Coates, L, et al.
Publicat: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
per: Helliwell, PS, et al.
Publicat: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
per: Coates, L, et al.
Publicat: (2016)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
per: Coates, L, et al.
Publicat: (2020)

Outcome measures in psoriatic arthritis: where next?
per: Hackett, S, et al.
Publicat: (2022)

Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis
per: Laure Gossec, et al.
Publicat: (2024-02-01)

Assessing disease activity in psoriatic arthritis: a literature review
per: Tucker, L, et al.
Publicat: (2018)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
per: Helliwell, PS, et al.
Publicat: (2023)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
per: Gladman, DD, et al.
Publicat: (2022)

Classification and outcome measures for psoriatic arthritis
per: Leung, Y, et al.
Publicat: (2018)

Sex-specific differences in patients with psoriatic arthritis: a systematic review
per: Coates, LC, et al.
Publicat: (2022)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
per: Vivekanantham, A, et al.
Publicat: (2024)

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review
per: Leung, Y-Y, et al.
Publicat: (2020)

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership: Recommended next steps
per: Tillett, W, et al.
Publicat: (2020)

How should we define disease and outcomes in axial psoriatic arthritis?
per: Coates, LC
Publicat: (2021)

Identification of psoriatic arthritis in patients with psoriasis
per: Coates, LC, et al.
Publicat: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
per: Soriano, ER, et al.
Publicat: (2023)

The State of the Art - Psoriatic Arthritis outcome assessment in clinical trials and daily practice
per: Day, J, et al.
Publicat: (2022)

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation
per: Coates, L, et al.
Publicat: (2016)

Psoriatic Arthritis: A Review
per: Farrouq Mahmood, et al.
Publicat: (2016-07-01)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
per: Atul Deodhar, et al.
Publicat: (2022-07-01)

Obesity and Psoriatic Arthritis: A Narrative Review
per: Anand Kumthekar, et al.
Publicat: (2020-06-01)

Psoriatic arthritis in developing and resource-poor countries
per: Maharaj, AB, et al.
Publicat: (2020)

Methotrexate in psoriasis and psoriatic arthritis
per: Coates, L, et al.
Publicat: (2020)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
per: Alexis Ogdie, et al.
Publicat: (2023-05-01)

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate
per: Coates, LC, et al.
Publicat: (2023)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
per: Braun, J, et al.
Publicat: (2023)